Log In
BCIQ
Print this Print this
 

Dbait

  Manage Alerts
Collapse Summary General Information
Company Onxeo S.A.
DescriptionShort inhibiting DNA (siDNA) which mimics DNA double strand breaks
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear DNA
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$30.3M

0

$1.1M


 Deals Details
Get a free BioCentury trial today